Robert Ernst Portmann
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Organic Chemistry Cycloaddition Reactions, Eicosanoids and Hypertension Pharmacology, Chemical Synthesis and Analysis, Fluorine in Organic Chemistry, Porphyrin and Phthalocyanine Chemistry
Most-Cited Works
- → Discovery of a Potent and Selective Protein Kinase CK2 Inhibitor by High-Throughput Docking(2003)215 cited
- → Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: A Potent, Orally Bioavailable Human CB1/CB2Dual Agonist with Antihyperalgesic Properties and Restricted Central Nervous System Penetration(2007)96 cited
- → Notiz zur Synthese Eines Optisch Aktiven Ace‐Hemmers mit Amino‐oxo‐benzazepin‐1‐alkansäure‐Struktur mittels enantiokonvergierender kristallisationsinduzierter Racemat‐Trennung(1988)36 cited
- → Synthese von 2‐Thia‐6‐aza‐adamantan und Derivaten(1971)19 cited
- → Heterotricyclodecane XIV. 2‐Oxa‐6‐aza‐adamantan und Derivate(1973)13 cited
- → Heterotricyclodecane XVI. 2‐Oxa‐7‐aza‐isotwistane und 2‐Oxa‐7‐aza‐twistane(1973)10 cited
- → Heterotricyclodecane XV. Synthese von 2,6‐Diaza‐adamantanen(1973)6 cited
- → Heterotricyclodecane XIX. Umlagerungen von 4,8‐disubstituierten 2,6‐Dioxa‐ und 2‐Oxa‐6‐aza‐adamantanen zu 4,10‐disubstituierten 2,7‐Dioxa‐ und 2‐Oxa‐7‐aza‐isotwistanen sowie ‐twistanen(1976)4 cited
- → ChemInform Abstract: Synthesis of an Optically Active ACE Inhibitor with Amino‐oxo‐benzazepine‐1‐alkanoic Acid Structure by Means of an Enantioconvergent Crystallization‐Based Resolution.(1988)1 cited
- → 2-Oxa-6-aza-, 2-Thia-6-aza- und 2,6-Diaza-adamantane sowie 2-Oxa-7-aza-isotwistane und -twistane(1974)